Novo Nordisk A/S (NOV.DE)

EUR 58.11

(-0.92%)

Revenue Summary of Novo Nordisk A/S

  • Novo Nordisk A/S's latest annual revenue in 2023 was 232.26 Billion DKK , up 31.28% from previous year.
  • Novo Nordisk A/S's latest quarterly revenue in 2024 Q2 was 68.06 Billion DKK , up 4.15% from previous quarter.
  • Novo Nordisk A/S reported a annual revenue of 23.72 Billion DKK in annual revenue 2022, up 25.32% from previous year.
  • Novo Nordisk A/S reported a annual revenue of 18.93 Billion DKK in annual revenue 2021, up 11.01% from previous year.
  • Novo Nordisk A/S reported a quarterly revenue of 8.73 Billion DKK for 2024 Q1, down -0.78% from previous quarter.
  • Novo Nordisk A/S reported a quarterly revenue of 31.14 Billion DKK for 2023 FY, up 31.28% from previous quarter.

Annual Revenue Chart of Novo Nordisk A/S (2023 - 2016)

Historical Annual Revenue of Novo Nordisk A/S (2023 - 2016)

Year Revenue Revenue Growth
2023 232.26 Billion DKK 31.28%
2022 23.72 Billion DKK 25.32%
2021 18.93 Billion DKK 11.01%
2020 17.05 Billion DKK 4.44%
2019 16.32 Billion EUR 8.97%
2018 14.98 Billion EUR -0.11%
2017 15 Billion EUR -0.21%
2016 15.03 Billion EUR 0.0%

Peer Revenue Comparison of Novo Nordisk A/S

Name Revenue Revenue Difference
BioNTech SE 3.81 Billion EUR -5981.723%
CureVac N.V. 53.75 Million EUR -431949.183%
Biotest Aktiengesellschaft 684.6 Million EUR -33826.526%
Biotest Aktiengesellschaft 684.6 Million EUR -33826.526%
BRAIN Biotech AG 55.33 Million EUR -419636.153%
Formycon AG 77.69 Million EUR -298835.595%
Heidelberg Pharma AG 9.85 Million EUR -2355748.191%
Medigene AG 6.03 Million EUR -3849104.508%